Belite Bio Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +76.5% | +560.0% | +101.5% | +12.5% | – | |
| – | – | – | – | – | – | |
| – | +101.2% | +19.5% | +180.1% | +20.5% | +51.6% | |
| – | +15.7% | +66.2% | +72.7% | +47.4% | +286.1% | |
| – | +70.6% | +30.9% | +147.0% | +26.3% | +110.5% | |
| – | – | – | – | – | – | |
| – | -76.2% | +220.0% | +56.3% | -20.0% | -90.0% | |
| – | – | – | – | – | – | |
| – | +12,500.0% | -237.3% | – | -33.3% | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.